Professor of Surgery, Case West Res University
Colon & Rectal Surgery
Dr. Ian C. Lavery, MD
|
|
Give Review
Doctor Ian C. Lavery, MD practices Colon & Rectal Surgery. He went to The University of Queensland Medical School. He over the years received 5 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification", "Northern Ohio Live" and "Fellow (FACS)". Dr. Ian C. Lavery is also published. He has 58 publications published. The lastest publication: "Factors associated with the location of local rectal cancer recurrence and predictors of survival.' Doctor Ian C. Lavery, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Factors associated with the location of local Rectal cancer recurrence and predictors of survival.
- Radiation therapy in patients with inflammatory bowel disease and coloRectal cancer: Risks and benefits.
- Perineal Wound Healing Following IleoAnal Pouch Excision.
- Less Than 12 Nodes in the Surgical Specimen After Total MesoRectal Excision Following Neoadjuvant Chemoradiation: It means more than you think!
- Impact of Obesity on Operation Performed, Complications, and Long-term Outcomes in Terms of Restoration of Intestinal Continuity for Patients With Mid and Low Rectal C...
- Erratum to: EndoRectal ultrasound does not reliably identify patients with uT3 Rectal cancer who can avoid neoadjuvant chemoradiotherapy.
- EndoRectal ultrasound does not reliably identify patients with uT3 Rectal cancer who can avoid neoadjuvant chemoradiotherapy.
- Gender differences in mortality, quality of life and function after restorative procedures for Rectal cancer.
- The predictive value of preoperative carcinoembryonic antigen level in the prognosis of colon Cancer.
- Is Adjuvant Chemotherapy Really Needed After Curative Surgery for Rectal Cancer Patients Who are Node-Negative After Neoadjuvant Chemoradiotherapy?
- Impact of early reoperation after resection for coloRectal cancer on long-term oncologic outcomes.
- Prone or lithotomy positioning during an abdominoperineal resection for Rectal cancer results in comparable oncologic outcomes.
- Pathologic complete response after neoadjuvant treatment for Rectal cancer decreases distant recurrence and could eradicate local recurrence.
- Gender of the patient may influence perioperative and long term complications after IPAA.
- Efficacy and safety of endoscopic treatment of ileal pouch strictures.
- Effects of chronic immunosuppression on long-term oncologic outcomes for coloRectal cancer patients undergoing surgery.
- Does a subcentimeter distal resection margin adversely influence oncologic outcomes in patients with Rectal cancer undergoing restorative proctectomy?
- Clinical implications of acellular mucin pools in resected Rectal cancer with pathological complete response to neoadjuvant chemoradiation.
- IleoRectal anastomosis and proctocolectomy with end ileostomy for ulcerative colitis.
- Preoperative coloRectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy.
- ColoRectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
- Gene signature is associated with early stage Rectal cancer recurrence.
- Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII Rectal cancers.
- Downstaging after chemoradiotherapy for locally advanced Rectal cancer: is there more (tumor) than meets the eye?
- How to evaluate risk and identify stage II patients requiring referral to a medical oncologist: a surgeon's perspective.
- Evaluation of association between precolectomy thrombocytosis and the occurrence of inflammatory pouch disorders.
- Predictive factors of pathologic complete response after neoadjuvant chemoradiation for Rectal cancer.
- Association between immune-associated disorders and adverse outcomes of ileal pouch-Anal anastomosis.
- The impact of anastomotic leak and intra-abdominal abscess on cancer-related outcomes after resection for coloRectal cancer: a case control study.
- Outcomes for patients developing anastomotic leak after ileal pouch-Anal anastomosis: does a handsewn vs. stapled anastomosis matter?
- Family history of Crohn's Disease is associated with an increased risk for Crohn's Disease of the pouch.
- Repeat pouch surgery by the abdominal approach safely salvages failed ileal pelvic pouch.
- Measuring sexual and urinary outcomes in women after Rectal cancer excision.
- Postoperative radiotherapy for stage IIIA Rectal cancer: is it justified?
- Long-term outcomes with ileal pouch-Anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis.
- Risk factors for pouch failure in patients with different phenotypes of Crohn's Disease of the pouch.
- Development of a clinically feasible molecular assay to predict recurrence of stage II colon Cancer.
- A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy.
- Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders.
- Clinical features and quality of life in patients with different phenotypes of Crohn's Disease of the ileal pouch.
- A meta-Analysis of quality of life for abdominoperineal excision of rectum versus anterior resection for rectal cancer.
- Plasma lysophosphatidylcholine levels: potential biomarkers for coloRectal cancer.
- The outcome after restorative proctocolectomy with or without defunctioning ileostomy.
- Risk factors for diseases of ileal pouch-Anal anastomosis after restorative proctocolectomy for ulcerative colitis.
- Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for Rectal cancer: a predictive model.
- Recurrence after transAnal excision of T1 rectal cancer: should we be concerned?
- Quality of life, functional outcome, and complications of coloplasty pouch after low anterior resection.
- Evaluation of the learning curve in ileal pouch-Anal anastomosis surgery.
- Assessment of operative risk in coloRectal cancer surgery: the Cleveland Clinic Foundation coloRectal cancer model.
- Functional outcome and quality of life after repeat ileal pouch-Anal anastomosis for complications of ileoAnal surgery.
- Quantification of risk for pouch failure after ileal pouch Anal anastomosis surgery.
- Prospective, age-related Analysis of surgical results, functional outcome, and quality of life after ileal pouch-Anal anastomosis.
- Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
- Dysplasia of the Anal transitional zone after ileal pouch-Anal anastomosis: results of prospective evaluation after a minimum of ten years.
- Intestinal malrotation: a rare but important cause of bowel obstruction in adults.
- Preoperative radiotherapy improves survival for patients undergoing total mesoRectal excision for stage T3 low Rectal cancers.
- Strictureplasty in diffuse Crohn's jejunoileitis: safe and durable.
Schools
University Of Queensland Faculty Of Health Sciences
Princess Alexandra Hospital
Cleveland Clinic
Procedures Preformed
- Anoscopy With Removal of Anal Tumor
- Colectomy
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Destruction of Anal Tumor
- View All
Conditions Treated
- Anal and Rectal Cancer
- Anal Fissure
- Anal Fistula
- AnoRectal Abscess
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medical Mutual of Ohio POS
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Northern Ohio Live
- Fellow (FACS)
Education
-
Cleveland Clinic Foundation -
The University of Queensland Medical School
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1518901073 | |
| NPPES Provider LastName | LAVERY | |
| NPPES Provider FirstName | IAN | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Colorectal Surgery (formerly proctology) | |
| Total Claim Count | 118.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518901073 |
| Last Name Of The Provider | LAVERY |
| First Name Of The Provider | IAN |
| View All |
Similar Doctors
|
|
Dr. Meagan M. Costedio, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jon D. Vogel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeremy M. Lipman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry W. Eisenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chucheep Sahakitrungruang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthias Turina, MD
This Doctor is OpenDoctor Recommended.
|